Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine vs Lamivudine for Renal Function in Post-transplant HBV
NCT02447705Phase 3Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jun 2013
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised trial of telbivudine in hepatitis B (HBV) (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Renal function measurement. Started Jun 2013; status: completed.
02
Drugs
telbivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02447705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447705.